Streetbeat News

Stock Prices

ACRS

SNES

TCBP

TIVC

VERV

In Monday's pre-market session, several healthcare stocks showed significant movement. Tivic Health Systems (TIVC) saw a 116.8% increase, while SenesTech (SNES) rose by 65.78%. ZyVersa Therapeutics (ZVSA) and Cingulate (CING) also experienced gains. On the downside, TC BioPharm (TCBP) dropped by 89.2%, Aclaris Therapeutics (ACRS) fell by 85.6%, and Verve Therapeutics (VERV) declined by 31.53%. Other stocks such as TRACON Pharma (TCON), Monopar Therapeutics (MNPR), and Singular Genomics Systems (OMIC) also saw decreases. Earnings reports seem to be a driving factor for many of these movements.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 1:06 pm

DXYN

Dixie Gr (NASDAQ:DXYN) reported a significant improvement in its Q3 earnings with a loss of $(0.15) per share compared to a loss of $(0.55) per share in the same quarter last year. Sales soared to $68.58 billion, marking a staggering increase from $71.76 million reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:06 pm

AREB

CPLP

CSLR

EFOI

FREY

ISUN

MTRX

PEGY

STAF

TYGO

WLGS

XOS

In Monday's pre-market session, several industrial stocks showed significant movement. Gainers included iSun, Complete Solaria, FREYR Battery, Tigo Energy, Capital Product Partners, and Xos with increases ranging from 7.43% to 20.8%. Losers were Matrix Service, American Rebel Holdings, Energy Focus, WANG & LEE Group, Pineapple Energy, and Staffing 360 Solutions with declines between 4.97% and 12.7%. Most movements were associated with recent Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 1:06 pm

AUUD

BTOG

COMS

CYN

GRRR

GSIT

HTCR

MLGO

MTC

OMQS

PRSO

In Monday's pre-market session, several IT stocks showed significant movement. Peraso, MMTEC, Cyngn, GSI Technology, HeartCore Enterprises, and ComSovereign Holding were gainers, with Peraso, Cyngn, and OMNIQ releasing Q3 earnings reports. Auddia, Gorilla Tech Gr, Bit Origin, Aurora Mobile, MicroAlgo, and OMNIQ were among the losers.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 1:06 pm

BBDC

WFC

Wells Fargo analyst Finian O'Shea has downgraded Barings BDC (BBDC) from Overweight to Equal-Weight and reduced the price target from $9 to $8.5.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:06 pm

JRSH

Jerash Holdings (US) reported a decrease in earnings per share (EPS) for Q2, with $0.03 compared to $0.14 year-over-year (YoY). Additionally, the company's sales of $33.36M fell short of the estimated $36.70M.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:06 pm

ALGS

Aligos Therapeutics presented clinical and nonclinical data at the AASLD Liver Meeting 2023, showing that its drug ALG-055009 has a favorable risk-benefit profile. This could potentially impact the company's stock as investors react to the positive news regarding the drug's development.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:05 pm

MNTK

Scotiabank analyst Paul Cheng has upgraded Montauk Renewables (NASDAQ:MNTK) from Sector Perform to Sector Outperform and set a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 1:04 pm

BKNG

Booking Holdings (NASDAQ:BKNG) has received 13 analyst ratings in the last quarter, with 5 bullish, 5 somewhat bullish, and 3 indifferent. There were no somewhat bearish or bearish ratings. The average price target is $3498.62, representing an implied upside from the current price of $3070. The average target has increased by 5.07% from the previous target of $3329.67. Analysts typically rate stocks quarterly or after major company updates, basing their ratings on financial predictions and company performance.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 1:00 pm

Guardant Health (NASDAQ:GH) received 7 analyst ratings in the last quarter, with 3 bullish, 4 somewhat bullish, and none bearish. The average price target is $41.57, representing an upside from the current price of $22.2. This target is a 20.44% decrease from the previous target of $52.25. Analysts rate stocks based on detailed research and provide guidance on performance metrics.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 1:00 pm